Deutsche Bank
AERI

Deutsche Bank’s Aerie Pharmaceuticals AERI Stock Holding History

Deutsche Bank’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-170
Closed -$6K – 5516
2018
Q4 		$6K Buy
170
+100
+143% +$4.69K ﹤0.01% 4964
2018
Q3 		$4K Hold
70
– – ﹤0.01% 5210
2018
Q2 		$5K Hold
70
– – ﹤0.01% 5262
2018
Q1 		$3K Sell
70
-100
-59% -$5.59K ﹤0.01% 5292
2017
Q4 		$10K Buy
+170
New +$10.3K ﹤0.01% 4780

Deutsche Bank's AERI Position: Q4 2022 in Review

Deutsche Bank sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 740,882 shares — an estimated $11.2M sold.

Deutsche Bank first reported a position in AERI in Q4 2013 and held it in 36 quarters. The position peaked at $31.4M in Q1 2017. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Deutsche Bank reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Deutsche Bank sold 740,882 Aerie Pharmaceuticals shares in Q4 2022, an estimated $11.2M.
  • Deutsche Bank first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 36 quarters.
  • Deutsche Bank's Aerie Pharmaceuticals position peaked at $31.4M in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Deutsche Bank's 13F filing for Q4 2022, filed 13 Feb 2023.